GlassScriptPhysician profile
Christopher Casstevens
NPI 1760758098
$13,415.35
in general payments reported to CMS, 2019-2025
18 companies · $2,881 in 2025
The $2,881 reported for 2025 was more than what 87% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $620 · 2020: $4,127 · 2021: $728 · 2022: $688 · 2023: $2,252 · 2024: $2,120 · 2025: $2,881.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,264 · Food and Beverage: $2,988.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,264.17 |
| Food and Beverage | $2,987.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,592.59 | 2020-2025 | |
| Trimed, INC. | $1,850.71 | 2023 | |
| Core Surgical Group | $1,629.74 | 2024-2025 | |
| Medinc of Texas | $1,554.72 | 2020 | |
| Axogen | $1,478.66 | 2019-2025 | Axoguard Ha+ Nerve Protector, Avance Nerve Graft |
| Stryker Corporation | $924.87 | 2019-2025 | Pangea, Gamma, Inspace |
| Pacira Pharmaceuticals Incorporated | $688.00 | 2022 | |
| Skeletal Dynamics INC | $467.75 | 2021-2025 | Ijs, Geminus, Align |
| Zimmer Biomet Holdings, INC. | $419.45 | 2024-2025 | Comprehensive Shoulder System, Oxford |
| Checkpoint Surgical, INC | $257.69 | 2021-2023 | Checkpoint Stimulators |
| Depuy Synthes Sales INC. | $234.85 | 2019-2025 | Na, Va-Lcp, Tfn-Advance |
| Wright Medical Technology, INC. | $140.43 | 2019 | |
| Acumed LLC | $51.72 | 2023 | Acumed, Innate Implant |
| Smith+Nephew, INC. | $42.87 | 2021-2023 | Integra, Ascension, First Choice Druj System |
| Fidia Pharma USA INC. | $26.31 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $22.36 | 2024 | Proclaim |
| Endo Pharmaceuticals INC. | $19.23 | 2019 | |
| Bioventus LLC | $13.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Casstevens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.